Educational Programme on Metastatic Pancreatic Cancer Now Available

February 15, 2025
share

Metastatic pancreatic ductal adenocarcinoma (mPDAC) is an aggressive and often late-diagnosed cancer with poor prognoses. Early detection remains critical but challenging due to non-specific symptoms.

To address this need, COR2ED has launched a two-part micro-learning programme in collaboration with Professors Efrat Dotan and Shubham Pant. This educational initiative provides essential insights into mPDAC, covering symptoms, risk factors, diagnostic tools, treatment strategies, and recent advancements in chemotherapy.

Digestive Cancers Europe (DiCE) acknowledges the importance of such resources in supporting healthcare professionals and improving patient outcomes. We encourage our community to explore this valuable programme, which includes concise tools such as slide sets, animated videos, and flashcards for efficient learning.

For more details, visit COR2ED’s website (link here) and join the effort to advance early detection and treatment of pancreatic cancer.

For more information about pancreatic cancer, please click here.

Author:

Laura Urena

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.